13 June 2018 - Deborah Wilkes
Archived
Johnson & Johnson has agreed to sell its LifeScan blood glucose monitoring business to private-equity firm Platinum Equity for around USD2.1 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.